Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Some herbs show promise as antiandrogenic agents.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Rats had lasting erectile problems after stopping a certain medication.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

Certain drugs change freshwater snail shells to a "banana" shape.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Purple corn extract may help reduce prostate enlargement and inflammation.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Finasteride may negatively affect male fertility.

Finasteride reduces movement issues in Parkinson's disease rats.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.